Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KORU vs GSK✓SelectedUSD · GSKKORU vs GSK performance historyLatest closeAs of-5.42%11/13
Stock and ETF performance explorer

KORU vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-63.9%
GSK return
+1.6%
Excess return
-65.5%
Maximum drawdown
-73.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.4%+0.5%-5.9%-4.7%
7D+11.1%+1.1%+10.0%+12.7%
30D-40.6%+6.3%-46.9%-34.9%
3M-63.9%+1.8%-65.7%-58.3%
All-63.9%+1.6%-65.5%-58.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3mo analysis · Full analysis span regression · Available span rolling